
Carol M. Koslow
Examiner (ID: 12920, Phone: (571)272-1371 , Office: P/1734 )
| Most Active Art Unit | 1734 |
| Art Unit(s) | 1734, 1754, 1793, 1755, 1108 |
| Total Applications | 5011 |
| Issued Applications | 4022 |
| Pending Applications | 258 |
| Abandoned Applications | 784 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16452576
[patent_doc_number] => 20200362002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => PROCESS FOR PROVIDING PEGYLATED PROTEIN COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/958114
[patent_app_country] => US
[patent_app_date] => 2018-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31008
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16958114
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/958114 | PROCESS FOR PROVIDING PEGYLATED PROTEIN COMPOSITION | Dec 27, 2018 | Pending |
Array
(
[id] => 14746771
[patent_doc_number] => 20190256559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/223474
[patent_app_country] => US
[patent_app_date] => 2018-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63343
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16223474
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/223474 | PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF | Dec 17, 2018 | Abandoned |
Array
(
[id] => 14099337
[patent_doc_number] => 20190091344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => AMPHIPATHIC PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 16/215183
[patent_app_country] => US
[patent_app_date] => 2018-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21078
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16215183
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/215183 | Amphipathic peptide | Dec 9, 2018 | Issued |
Array
(
[id] => 14158707
[patent_doc_number] => 20190106456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => COMPOUNDS FOR DELIVERING GLUTATHIONE TO A TARGET AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/212500
[patent_app_country] => US
[patent_app_date] => 2018-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13380
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16212500
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/212500 | COMPOUNDS FOR DELIVERING GLUTATHIONE TO A TARGET AND METHODS OF MAKING AND USING THE SAME | Dec 5, 2018 | Abandoned |
Array
(
[id] => 14338863
[patent_doc_number] => 20190151404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF DRY EYE DISEEASE
[patent_app_type] => utility
[patent_app_number] => 16/205112
[patent_app_country] => US
[patent_app_date] => 2018-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26816
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16205112
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/205112 | THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF DRY EYE DISEEASE | Nov 28, 2018 | Abandoned |
Array
(
[id] => 14342157
[patent_doc_number] => 20190153051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => FUSION PROTEIN OF C2 DOMAIN AND AKT KINASE DOMAIN FRAGMENT AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/198088
[patent_app_country] => US
[patent_app_date] => 2018-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16198088
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/198088 | FUSION PROTEIN OF C2 DOMAIN AND AKT KINASE DOMAIN FRAGMENT AND USE THEREOF | Nov 20, 2018 | Abandoned |
Array
(
[id] => 14277859
[patent_doc_number] => 20190136214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => GENERATION OF STABLE PROTEIN FILMS USING FLUOROUS SOLVENT
[patent_app_type] => utility
[patent_app_number] => 16/180260
[patent_app_country] => US
[patent_app_date] => 2018-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16180260
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/180260 | Generation of stable protein films using fluorous solvent | Nov 4, 2018 | Issued |
Array
(
[id] => 15381851
[patent_doc_number] => 10532084
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-14
[patent_title] => Chondrocyte extracellular matrix-derived peptide
[patent_app_type] => utility
[patent_app_number] => 16/178618
[patent_app_country] => US
[patent_app_date] => 2018-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 19
[patent_no_of_words] => 8434
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16178618
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/178618 | Chondrocyte extracellular matrix-derived peptide | Nov 1, 2018 | Issued |
Array
(
[id] => 15395829
[patent_doc_number] => 10538558
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-21
[patent_title] => Inhibition of TCR signaling with peptide variants
[patent_app_type] => utility
[patent_app_number] => 16/166984
[patent_app_country] => US
[patent_app_date] => 2018-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 29322
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16166984
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/166984 | Inhibition of TCR signaling with peptide variants | Oct 21, 2018 | Issued |
Array
(
[id] => 13982637
[patent_doc_number] => 20190060476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => CROSS-LINKED COLLAGEN COMPRISING METALLIC ANTICANCER AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/161441
[patent_app_country] => US
[patent_app_date] => 2018-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14605
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16161441
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/161441 | CROSS-LINKED COLLAGEN COMPRISING METALLIC ANTICANCER AGENTS | Oct 15, 2018 | Abandoned |
Array
(
[id] => 16252169
[patent_doc_number] => 20200261543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => COMBINATION THERAPY FOR TREATMENT OF BONE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/754944
[patent_app_country] => US
[patent_app_date] => 2018-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11262
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16754944
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/754944 | COMBINATION THERAPY FOR TREATMENT OF BONE DISORDERS | Oct 10, 2018 | Abandoned |
Array
(
[id] => 14649455
[patent_doc_number] => 20190231856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING INTRACEREBRAL HEMORRHAGE
[patent_app_type] => utility
[patent_app_number] => 16/157194
[patent_app_country] => US
[patent_app_date] => 2018-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16565
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16157194
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/157194 | COMPOSITIONS AND METHODS FOR TREATING INTRACEREBRAL HEMORRHAGE | Oct 10, 2018 | Abandoned |
Array
(
[id] => 14227639
[patent_doc_number] => 20190125992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => INTRANASAL ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 16/142646
[patent_app_country] => US
[patent_app_date] => 2018-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16142646
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/142646 | INTRANASAL ADMINISTRATION | Sep 25, 2018 | Abandoned |
Array
(
[id] => 17133695
[patent_doc_number] => 11135230
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Lipid compositions with high DHA content
[patent_app_type] => utility
[patent_app_number] => 16/133185
[patent_app_country] => US
[patent_app_date] => 2018-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 18163
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 205
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16133185
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/133185 | Lipid compositions with high DHA content | Sep 16, 2018 | Issued |
Array
(
[id] => 15604307
[patent_doc_number] => 10583194
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-10
[patent_title] => Minimally toxic prodrugs
[patent_app_type] => utility
[patent_app_number] => 16/133684
[patent_app_country] => US
[patent_app_date] => 2018-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 26438
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16133684
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/133684 | Minimally toxic prodrugs | Sep 16, 2018 | Issued |
Array
(
[id] => 15280091
[patent_doc_number] => 10512695
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-24
[patent_title] => Fast dissolving pharmaceutical composition
[patent_app_type] => utility
[patent_app_number] => 16/115650
[patent_app_country] => US
[patent_app_date] => 2018-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7790
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16115650
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/115650 | Fast dissolving pharmaceutical composition | Aug 28, 2018 | Issued |
Array
(
[id] => 16598062
[patent_doc_number] => 20210024593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => MODIFIED HEAT SHOCK PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/641013
[patent_app_country] => US
[patent_app_date] => 2018-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29052
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16641013
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/641013 | MODIFIED HEAT SHOCK PROTEINS | Aug 23, 2018 | Abandoned |
Array
(
[id] => 15990583
[patent_doc_number] => 20200171162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => E-POLY-L-LYSINE DERIVATIVES HAVING FUNCTIONAL GROUP FOR CLICK CHEMISTRY, METHOD FOR PRODUCING THE SAME, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/640468
[patent_app_country] => US
[patent_app_date] => 2018-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13023
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16640468
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/640468 | E-POLY-L-LYSINE DERIVATIVES HAVING FUNCTIONAL GROUP FOR CLICK CHEMISTRY, METHOD FOR PRODUCING THE SAME, AND USE THEREOF | Aug 22, 2018 | Abandoned |
Array
(
[id] => 14069501
[patent_doc_number] => 20190083638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => NICLOSAMIDE-CONJUGATED POLYPEPTIDE NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 16/045556
[patent_app_country] => US
[patent_app_date] => 2018-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16045556
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/045556 | NICLOSAMIDE-CONJUGATED POLYPEPTIDE NANOPARTICLES | Jul 24, 2018 | Abandoned |
Array
(
[id] => 16807855
[patent_doc_number] => 20210130408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => COMPOUND AND METHOD FOR PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/633701
[patent_app_country] => US
[patent_app_date] => 2018-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9189
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16633701
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/633701 | COMPOUND AND METHOD FOR PRODUCING THE SAME | Jul 23, 2018 | Pending |